ClinicalTrials.gg
Not yet recruitingNCT07722858PT-BURNOUT-TRUpdated Jul 23, 2026

Factors Affecting Burnout in Physiotherapists in Turkey

An observational study in Burnout, Professional, Occupational Stress and Psychological Resilience, sponsored by Acibadem University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-23.

Sponsored by Acibadem University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
400
Ages
18 Years and older
Sex
All
01

Study summary

This cross-sectional descriptive study aims to identify the demographic, occupational, organisational and individual psychological factors that predict burnout among physiotherapists working in active clinical practice in Turkey. Using a four-block hierarchical multiple regression approach, the relative contribution of workload and role factors, organisational factors, psychological resilience, self-efficacy and Type A behaviour pattern to the three dimensions of burnout (emotional exhaustion, depersonalisation and personal accomplishment) will be quantified. Turnover intention is examined as a secondary dependent variable. Data are collected through an anonymous online survey distributed nationwide.

02

Conditions studied

  • Burnout, Professional
  • Occupational Stress
  • Psychological Resilience
  • Self Efficacy

Keywords

  • Burnout
  • Physiotherapists
  • Physical therapy
  • Occupational health
  • Psychosocial work environment
  • Resilience
  • Self-efficacy
  • Type A behaviour pattern
  • Turnover intention
  • Hierarchical regression
03

In context

Burnout, Professional

216 studies on the registry are indexed under Burnout, Professional; 33 are open to participants now.

This study's planned enrollment of 400 is above the median of 223 across 52 observational studies indexed under Burnout, Professional.

Browse Burnout, Professional studies →

Lead sponsor

Acibadem University is the lead sponsor of 220 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Licensed physiotherapists in active clinical practice in Turkey, working across a range of sectors and clinical fields. Participants are recruited nationwide by snowball and purposive sampling through the Turkish Physiotherapy Association, professional social media groups and university physiotherapy departments.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Licensed physiotherapist in Turkey
  • Currently working in active clinical practice
  • Provides electronic

Exclusion criteria

Exclusion Criteria:

  • Not currently working in clinical practice
  • Incomplete questionnaire, defined as responding to less than 50 percent of the COPSOQ III items
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
400 participants (estimated)
Patient registry
No

Groups and cohorts

  • Physiotherapists in active clinical practice in Turkey

    Licensed physiotherapists working in active clinical practice across Turkey, recruited nationwide through professional associations, professional social media groups and university physiotherapy departments. Participants complete a single anonymous online questionnaire battery; no intervention is applied.

06

What researchers measure

Primary outcomes

  1. Burnout (Maslach Burnout Inventory, MBI)

    The MBI is a 22-item self-report instrument assessing burnout in three subscales: emotional exhaustion (9 items), depersonalisation (5 items) and personal accomplishment (8 items). Items are rated on a five-category frequency scale from 0 (never) to 4 (always). The personal accomplishment subscale is reverse scored, so that lower scores on that subscale indicate greater burnout; higher scores on emotional exhaustion and depersonalisation indicate greater burnout. Each subscale is analysed as a separate dependent variable.

    Time frame: Single assessment at enrollment (Day 1)

Secondary outcomes

  1. Turnover intention (Mobley Turnover Intention Scale)

    A 3-item scale assessing intention to leave the current job across three dimensions: thinking of quitting, intention to search for alternative employment and probability of leaving. Items are rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree), giving a total score of 3 to 15. Higher scores indicate greater turnover intention. Used as a secondary dependent variable.

    Time frame: Single assessment at enrollment (Day 1)

  2. Psychosocial work environment (Copenhagen Psychosocial Questionnaire III, COPSOQ III)

    COPSOQ III comprises 87 items across 25 subscales. Each subscale is scored separately on a 0 to 100 scale, with 0 to 33 indicating low risk, 33 to 66 moderate risk and 66 to 100 high risk. Job satisfaction items use a 4-point Likert format and the remaining dimensions a 5-point Likert format. High scores on quantitative demands, emotional demands and role conflict are interpreted as risk factors, whereas high scores on the remaining subscales are interpreted as protective factors. Workload, role and organisational subscales serve as predictor blocks in the regression models.

    Time frame: Single assessment at enrollment (Day 1)

  3. Psychological resilience (Connor-Davidson Resilience Scale, CD-RISC-10)

    The 10-item short form of the Connor-Davidson Resilience Scale, assessing coping with adversity, adaptation to change, seeking social support and self-confidence over the past month. Items are rated from 0 (not true at all) to 4 (true nearly all the time), giving a total score of 0 to 40. Higher scores indicate greater resilience. There are no reverse-scored items.

    Time frame: Single assessment at enrollment (Day 1)

  4. General self-efficacy (Self-Efficacy Scale)

    A 17-item scale assessing general perceived self-efficacy in coping with everyday difficulties, maintaining goal-directed behaviour and dealing effectively with novel situations. Items are rated on a 5-point Likert scale from 1 to 5, giving a total score of 17 to 85, with higher scores indicating greater perceived self-efficacy. Eleven items are reverse worded and are reverse coded before analysis.

    Time frame: Single assessment at enrollment (Day 1)

  5. Type A behaviour pattern (Bortner Rating Scale, short form)

    A bipolar 7-item scale based on the Type A and Type B personality model. For each item a value between 1 and 8 is selected, with the left pole representing Type B (calm, less competitive) and the right pole Type A (hurried, highly competitive) characteristics. The raw total is multiplied by three to obtain the final score, ranging from 21 to 168; scores of 100 and above indicate Type A and scores below 100 indicate Type B characteristics.

    Time frame: Single assessment at enrollment (Day 1)

07

Study locations

1 site
  • Acibadem Mehmet Ali Aydinlar University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
    Istanbul, 34752, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07722858
Responsible party
Hasan Gerçek (Assistant Professor, Acibadem University) — Principal investigator
First posted
Jul 23, 2026
Start date
Jul 2026 (estimated)
Primary completion
Jan 2027 (estimated)
Completion
Jan 2027 (estimated)
Last update
Jul 23, 2026

Study contacts

Hasan Gercek, PhD
Contact
hasan.gercek@acibadem.edu.tr
+90 542 648 8455
Nuray Alaca, PhD
Contact
nuray.alaca@acibadem.edu.tr
+90 532 425 1290
Hasan Gercek, PhD
principal investigator · Acibadem University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion